By: KDKA-TV News Staff
” Ab8 not just has potential as therapy for COVID-19, but it likewise might be used to keep people from getting SARS-CoV-2 infections,” said co-author John Mellors, M.D., chief of the Division of Infectious Diseases at UPMC and Pitt, stated in a release from UPMC. “Antibodies of bigger size have worked versus other infectious illness and have actually been well endured, giving us hope that it might be an effective treatment for patients with COVID-19 and for defense of those who have actually never had the infection and are not immune.”
The scientists reported that Ab8 is “highly efficient” in treating and preventing SARS-CoV-2 infection in mice and hamsters.
Stay with KDKA for more on this developing story.
PITTSBURGH (KDKA)– University of Pittsburgh scientists have actually separated a biomolecule that “completely and specifically” reduces the effects of the virus that triggers coronavirus.
University of Pittsburgh School of Medicine researchers isolated the tiniest biological molecule to date that neutralizes the SARS-CoV-2 infection, according to a report released Monday in the journal Cell. The antibody component is 10 times smaller sized than a full-sized antibody and has actually been used to develop a drug known as Ab8 for usage as a preventative and restorative against SARS-CoV-2, the report says.